Aspiriant LLC’s ETRACS Alerian MLP Index ETN AMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-11,907
Closed -$163K 223
2020
Q2
$163K Buy
+11,907
New +$98.7K 0.02% 179
2019
Q4
Sell
-218,848
Closed -$3.21M 217
2019
Q3
$3.21M Sell
218,848
-237,456
-52% -$3.61M 0.29% 48
2019
Q2
$7.19M Sell
456,304
-105,477
-19% -$1.67M 0.6% 33
2019
Q1
$9M Sell
561,781
-723,910
-56% -$11.4M 0.74% 27
2018
Q4
$18M Buy
1,285,691
+592,818
+86% +$9.43M 1.36% 18
2018
Q3
$12M Sell
692,873
-38,338
-5% -$673K 1.02% 22
2018
Q2
$12.1M Sell
731,211
-14,595
-2% -$240K 1.03% 24
2018
Q1
$11.2M Buy
745,806
+517,268
+226% +$8.89M 0.98% 24
2017
Q4
$3.96M Buy
228,538
+32,897
+17% +$562K 1.16% 23
2017
Q3
$3.48M Sell
195,641
-20,385
-9% -$369K 0.29% 51
2017
Q2
$4.05M Buy
216,026
+37,713
+21% +$730K 0.35% 47
2017
Q1
$3.62M Sell
178,313
-55,566
-24% -$1.14M 0.31% 55
2016
Q4
$4.65M Sell
233,879
-4,277
-2% -$82.1K 0.42% 34
2016
Q3
$4.72M Sell
238,156
-18,803
-7% -$372K 0.47% 32
2016
Q2
$5.13M Sell
256,959
-74,906
-23% -$1.4M 0.48% 35
2016
Q1
$5.64M Sell
331,865
-1,833,441
-85% -$29.1M 0.54% 28
2015
Q4
$39.5M Buy
2,165,306
+1,196,131
+123% +$23.1M 4.34% 9
2015
Q3
$18.5M Buy
969,175
+697,066
+256% +$15.8M 1.54% 17
2015
Q2
$6.81M Buy
272,109
+133,595
+96% +$3.66M 0.66% 17
2015
Q1
$3.74M Sell
138,514
-94,099
-40% -$2.62M 0.49% 17
2014
Q4
$6.75M Buy
+232,613
New +$7.17M 0.9% 15

Other funds holding AMU

Aspiriant LLC's AMU Position: Q3 2020 in Review

Aspiriant LLC sold out of ETRACS Alerian MLP Index ETN (AMU) in Q3 2020, closing a stake of 11,907 shares — an estimated $163K sold.

Aspiriant LLC first reported a position in AMU in Q4 2014 and held it in 21 quarters. The position peaked at $39.5M in Q4 2015. 15 funds tracked by Wall St. Rank hold AMU as of Q3 2020.

  • Aspiriant LLC reported no remaining ETRACS Alerian MLP Index ETN position as of Q3 2020 after selling out during the quarter.
  • Aspiriant LLC sold 11,907 ETRACS Alerian MLP Index ETN shares in Q3 2020, an estimated $163K.
  • Aspiriant LLC first reported a position in ETRACS Alerian MLP Index ETN in Q4 2014 and held it in 21 quarters.
  • Aspiriant LLC's ETRACS Alerian MLP Index ETN position peaked at $39.5M in Q4 2015.
  • 15 funds tracked by Wall St. Rank held ETRACS Alerian MLP Index ETN as of Q3 2020.

Based on Aspiriant LLC's 13F filing for Q3 2020, filed 29 Oct 2020.